Real‐life efficacy and safety of idelalisib in 55 double‐refractory follicular lymphoma patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Real‐life efficacy and safety of idelalisib in 55 double‐refractory follicular lymphoma patients

Published:2022-08-24 Issue:3 Volume:199 Page:339-343
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Isidori Alessandro¹^ORCID,Loscocco Federica¹,Visani Giuseppe¹,Paolasini Sara¹,Scalzulli Potito²,Musto Pellegrino³,Perrone Tommasina³,Guarini Attilio⁴,Pastore Domenico⁵,Mazza Patrizio⁶,Tonialini Lorenzo⁷,Pavone Vincenzo⁷,De Santis Gaetano⁸,Tarantini Giuseppe⁸

Affiliation:

1. Hematology and Stem Cell Transplant Center AORMN Hospital Pesaro Italy

2. UOC di Ematologia San Giovanni Rotondo San Giovanni Rotondo Italy

3. UOC di Ematologia Bari Policlinico Bari Italy

4. UOC di Ematologia Bari Oncologico Bari Italy

5. UOC di Ematologia Brindisi Brindisi Italy

6. UOC di Ematologia Taranto Taranto Italy

7. UOC di Ematologia Tricase Tricase Italy

8. UOC di Ematologia Barletta Barletta Italy

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.18426

Reference15 articles.

1. The Natural History of Initially Untreated Low-Grade Non-Hodgkin's Lymphomas

2. Selective inhibitors of phosphoinositide 3-kinase delta: modulators of B-cell function with potential for treating autoimmune inflammatory diseases and B-cell malignancies

3. PI3Kδ Inhibition by Idelalisib in Patients with Relapsed Indolent Lymphoma

4. Follicular Lymphoma International Prognostic Index

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gene targeted and immune therapies for nodal and gastrointestinal follicular lymphomas;World Journal of Gastroenterology;2023-12-28

2. Recent advances in treatment of nodal and gastrointestinal follicular lymphoma;World Journal of Gastroenterology;2023-06-21

3. Combined BCL-2 and PI3K/AKT Pathway Inhibition in KMT2A-Rearranged Acute B-Lymphoblastic Leukemia Cells;International Journal of Molecular Sciences;2023-01-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3